Michael J Knauer (Michael Knauer)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 10

Top Venues

Molecular medicine (Cambridge, Mass.)

ACS omega

F1000Research

BMJ open quality

London Health Sciences Centre

University of Western Ontario (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

London Health Sciences Centre Dec 18 2017

Canada

Clinical Biochemist :: Pathology and Laboratory Medicine

Education History

University of Western Ontario Sep 01 2007 - Dec 31 2012

Canada

PHD

Publications

Michael J Knauer, Ivan Stevic, Christine MacDonald, Vipin Bhayana, Jade Bolsover, Lori Smith, Ian H Chin-Yee
Every Tube Counts: reducing extra tubes drawn in the emergency department. BMJ open quality 12 (4) (2023)
Maitray A Patel, Michael J Knauer, Michael Nicholson, Mark Daley, Logan R Van Nynatten, Gediminas Cepinskas, Douglas D Fraser
Organ and cell-specific biomarkers of Long-COVID identified with targeted proteomics and machine learning. Molecular medicine (Cambridge, Mass.) 29 (1) (2023)
Nicole A Sidor, Thomas J Velenosi, Gilles A Lajoie, Guido Filler, Andrew A House, Matthew A Weir, Benjamin Ka Thomson, Amit X Garg, Justin B Renaud, Tim McDowell, Michael J Knauer, Rommel G Tirona, Rebecca Noble, Nicholas Selby, Maarten Taal, Bradley L Urquhart
Investigation of N , N , N -Trimethyl-L-alanyl-L-proline Betaine (TMAP) as a Biomarker of Kidney Function. ACS omega 8 (17) (2023)
Nicole A Sidor, Thomas J Velenosi, Gilles A Lajoie, Guido Filler, Andrew A House, Matthew A Weir, Benjamin Ka Thomson, Amit X Garg, Justin B Renaud, Tim McDowell, Michael J Knauer, Rommel G Tirona, Rebecca Noble, Nicholas Selby, Maarten Taal, Bradley L Urquhart
Investigation of N , N , N -Trimethyl-L-alanyl-L-proline Betaine (TMAP) as a Biomarker of Kidney Function. ACS omega 8 (17) (2023)
Maitray A Patel, Michael J Knauer, Michael Nicholson, Mark Daley, Logan R Van Nynatten, Gediminas Cepinskas, Douglas D Fraser
Organ and cell-specific biomarkers of Long-COVID identified with targeted proteomics and machine learning. Molecular medicine (Cambridge, Mass.) 29 (1) (2023)
Maitray A Patel, Michael J Knauer, Michael Nicholson, Mark Daley, Logan R Van Nynatten, Gediminas Cepinskas, Douglas D Fraser
Organ and cell-specific biomarkers of Long-COVID identified with targeted proteomics and machine learning. Molecular medicine (Cambridge, Mass.) 29 (1) (2023)
Maitray A Patel, Michael J Knauer, Michael Nicholson, Mark J Daley, Logan R Van Nynatten, Claudio M Martin, Eric K Patterson, Gediminas Cepinskas, Shannon L Seney, Verena Dobretzberger, Markus Miholits, Brian Webb, Douglas D Fraser
Elevated vascular transformation blood biomarkers in Long-COVID indicate angiogenesis as a key pathophysiological mechanism. Molecular medicine (Cambridge, Mass.) 28 (1) (2022)
Mark Cattral, Sean Luke, Michael J Knauer, Andrea Norgate, Jeffrey Schiff, Norman Muirhead, Patrick P Luke
Randomized open-label crossover assessment of Prograf vs Advagraf on immunosuppressant pharmacokinetics and pharmacodynamics in simultaneous pancreas-kidney patients. Clinical transplantation 32 (2) (2018)
Angela W S Fung, Michael J Knauer, Ivan M Blasutig, David A Colantonio, Vathany Kulasingam
Evaluation of electrochemiluminescence immunoassays for immunosuppressive drugs on the Roche cobas e411 analyzer. F1000Research 6 (2017)
Angela W S Fung, Michael J Knauer, Ivan M Blasutig, David A Colantonio, Vathany Kulasingam
Evaluation of electrochemiluminescence immunoassays for immunosuppressive drugs on the Roche cobas e411 analyzer. F1000Research (2017)

Michael J Knauer.css-eqlu8i{font-size:small;padding-left:4px;} (Michael Knauer)

Publication Activity (10 Years)

Top Topics

Top Venues

Michael J Knauer (Michael Knauer)